Software developer Virtify has integrated Kallik’s Automated Artwork Generation technology to its labelling solution for pharmaceutical and life science companies.

The new solution enables the creation and management of labelling and product information in several languages.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It also delivers print-ready packaging and labelling artwork, allowing pharmaceutical companies to generate final, consistent and compliant outputs from structured, single-source content.

The Automated Artwork Generation technology allows Virtify to deliver end-to-end solution and compliant labelling from structured content, covering both the pre-submission and post-submission workspaces.

Kallik Limited CEO Neil Gleghorn said by integrating structured content-centric technology, pharma companies can manage patient information from core data sheets through the spectrum of labelling and packaging.

”We estimate that manual transactions can be reduced by 90-95%, potentially saving large pharmaceutical companies tens of millions of pounds," Gleghorn added.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Virtify CEO and founder Satish Tadikonda said the partnership agreement with Kallik allows Virtify to provide complete solutions in the regulatory, supply chain and compliance areas.

”This partnership will allow pharmaceutical companies to evaluate an end-to-end solution for global labelling as opposed to assessing many vendors in siloed organisations," Tadikonda added.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact